Concepedia

Bernard J. Komoroski

BJ

Statistics

Publications

12

Citations

1.9K

H-Index

12

Active since

1999

Affiliations

University of Pittsburgh(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Germany)

University of Chicago

Bristol-Myers Squibb (Sweden)

Bernard J. Komoroski is an author at University of Pittsburgh specializing in psychiatry, neuropharmacology, and schizophrenia.

Top concepts

Publications per year

1999–2011

12

Publications

12

Disrupted Bile Acid Homeostasis Reveals an Unexpected Interaction among Nuclear Hormone Receptors, Transporters, and Cytochrome P450

Erin G. Schuetz, Stephen C. Strom, Kazuto Yasuda et al. · Journal of Biological Chemistry · 2001 · 386 citations · Full text

Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus

Bernard J. Komoroski, N. Vachharajani, L Li et al. · Clinical Pharmacology & Therapeutics · 2009 · 383 citations

Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects

Bernard J. Komoroski, N. Vachharajani, David W. Boulton et al. · Clinical Pharmacology & Therapeutics · 2009 · 342 citations

INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN’S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES

Bernard J. Komoroski, Shimin Zhang, Hongbo Cai et al. · Drug Metabolism and Disposition · 2004 · 180 citations

In Vitro Characterization and Pharmacokinetics of Dapagliflozin (BMS-512148), a Potent Sodium-Glucose Cotransporter Type II Inhibitor, in Animals and Humans

Mary T. Obermeier, Ming Yao, Ashish Khanna et al. · Drug Metabolism and Disposition · 2009 · 176 citations

Rows per page

1–5 of 12